Phase 2
๐ Investigational Drug / Biologic
NCT06107374
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
๐ University of Iowa Hospitals and Clinics โ Iowa City, Iowa
View Study & Screener โ